poisar

Stocks · News reference

Tempus AI Partners with SOTERIA to Advance Precision Oncology for Military and Veterans

Fiscal.ai

Tempus AI has entered a collaboration with the SOTERIA Precision Medicine Foundation to provide genomic sequencing and AI-driven insights to active-duty service members and veterans.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Tempus AI, Inc. (TEM)

    Filed: 2026-11-18 AccNo: 0001193125-26-466240 Size: 212 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits